# A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

> **NCT07412470** · PHASE2,PHASE3 · RECRUITING · sponsor: **Sanofi** · enrollment: 526 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **DRUG:** Frexalimab
- **DRUG:** Frexalimab
- **DRUG:** Tacrolimus
- **DRUG:** rabbit anti-thymocyte globulin
- **DRUG:** mycophenolate mofetil
- **DRUG:** mycophenolate sodium
- **DRUG:** methylprednisolone
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT07412470
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-13
- **Primary completion:** 2029-08-15
- **Final completion:** 2033-08-15
- **Target enrollment:** 526 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412470, "A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07412470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*